Vestibular Rehabilitation Therapy (VRT)
Treatment for Menieres Disease
Typical Dosage: 30-60 min sessions, 1-3 times/week
Effectiveness
65%
Safety Score
95%
Clinical Trials
1
Participants
6K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 min sessions, 1-3 times/week
Time to Effect
4-12 weeks
Treatment Duration
6-12 weeks initial course, then home exercises
Evidence Quality
MODERATEConfidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$150
Side Effect Mgmt:$0
Total Annual:$750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$1,000
Prescription Access Economics
Annual Societal Loss per Patient
$140
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$40/year
Travel + wait time
Insurance Admin Cost
$100/year
Prior auth, claims
Rx Price
$750/year
Potential OTC Price
$400/year
Estimated if OTC available
Early Treatment Benefit
+0.10 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWVestibular Rehabilitation Therapy (VRT) Outcomes
for Menieres Disease
Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+75%
Common Side Effects
Temporary increase in dizziness
+10%
Fatigue
+5%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov